Table 3 The prevalence of clinical features associated with PKD in people with PKD and people without
People with PKD | People without PKD | |||
|---|---|---|---|---|
n (%) | mean (SEM) | n (%) | mean (SEM) | |
Female | 137 (53.7) | 331,562 (48.5) | ||
Age | 255 (100.0) | 41.48 (12.83) | 684,257 (100.0) | 31.47 (16.88) |
CKD stage | ||||
No impairment | 97 (38.0) | 149,848 (21.9) | ||
Stage 3A | 26 (10.2) | 8,608 (1.3) | ||
Stage 3B | 17 (6.7) | 372 (0.1) | ||
Stage 4 | 17 (6.7) | 152 (0.0) | ||
Stage 5 | 17 (6.7) | 222 (0.0) | ||
Not measured | 81 (31.8) | 525,055 (76.7) | ||
Proteinuria | ||||
Negative | 87 (34.1) | 186,446 (27.2) | ||
Positive | 126 (49.4) | 21,735 (3.2) | ||
Not measured | 42 (16.5) | 476,076 (69.6) | ||
Haemoglobin | 29 (11.4) | 14.1 g/dl (1.2) | 41,243 (6.0) | 13.8 g/dl (1.6) |
Haematuria | 31 (12.2) | 22,452 (3.3) | ||
Urinary tract infections | 26 (10.2) | 24,123 (3.5) | ||
Mean systolic BP | 27 (10.6)* | 129.5 mmHg (15.9) | 42,294 (6.2) | 124.7 mmHg (14.8) |
Mean diastolic BP | 27 (10.6)* | 78.7 mmHg (9.0) | 42,510 (6.2) | 77.1 mmHg (9.4) |
Highest systolic BP | 27 (10.6)* | 146.2 mmHg (26.1) | 42,522 (6.2) | 132.4 mmHg (18.8) |
Highest diastolic BP | 27 (10.6)* | 91.5 mmHg (16.6) | 42,510 (6.2) | 82.3 mmHg (11.8) |
Diastolic BP over 90 mmHg | 17 (6.7) | 10,776 (1.6) | ||
Diabetes | 13 (5.1) | 15,988 (2.3) | ||
Multiple antihypertensives | 53 (20.8) | 8,911 (1.3) | ||